1. The weight of pre-existing cofactors for liver disease progression in patients who successfully eradicated HCV virus infection: An interim analysis in the PITER cohort. (February 2020) Authors: Kondili, L.A.; Quaranta, M.G.; Monti, M.; Amoruso, D.A.; Filomia, R.; Biliotti, E.; Iannone, A.; Ieluzzi, D.; Coco, B.; Russo, F.P.; Beretta, I.; Parruti, G.; Blanc, P.; Vinci, M.; Cossiga, V.; Degasperi, E.; Chemello, L.; Massari, M.; Badia, L.; Puoti, M. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e7 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen. (February 2020) Authors: Di Maio, V.C.; Aragri, M.; Masetti, C.; Paolucci, S.; Bruzzone, B.; Degasperi, E.; Barbaliscia, S.; Pollicino, T.; Minichini, C.; Calvaruso, V.; Rendina, M.; Cento, V.; Teti, E.; Micheli, V.; Allice, T.; Polilli, E.; Palitti, V. Pace; Landonio, S.; Lenci, I.; Francioso, S. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗